Health
New antitumor vaccines control melanoma growth in preclinical models – News-Medical.Net
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical m…
Reviewed by Emily Henderson, B.Sc.Sep 11 2020
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical models.
Study results were published online in Cancer Immunology Research, a journal of the American Association for Cancer Research, and support exploration of this immunotherapy approach for a…
-
Noosa News21 hours agoBrisbane council budget 2025: Winners and losers
-
Business16 hours ago3 of the best ASX stocks to buy now with $2,500
-
Noosa News15 hours agoRapist who tortured woman for weeks claims he deserves a lighter sentence for not letting her die
-
General10 hours agoSeeking a reset on the environment debate, Murray Watt gathers business and conservation groups in search of a deal